A rotavirus-vectored bivalent vaccine elicits protective immunity against bovine coronavirus and rotavirus

Bovine rotavirus (BRV) and bovine coronavirus (BCoV) are major causes of neonatal calf diarrhea and frequently occur as co-infections. Here, we engineered the Lanzhou lamb rotavirus vaccine strain LLR to express either the N-terminal domain (NTD) or the C-terminal domain (CTD) of the BCoV spike S1 subunit from a modified genome segment 8. The resulting viruses, rLLR-GSG-P2A-BCoV NTD and rLLR-GSG-P2A-BCoV CTD, replicated efficiently in cell culture, stably retained the inserted sequences through serial passage, and expressed the corresponding BCoV antigens. In a mouse model, oral inoculation of neonatal mice induced systemic antibody responses against both RV and BCoV. Maternal immunization in mice protected suckling mice against RV challenge and conferred partial protection against BCoV-associated diarrhea. In pregnant cows, intramuscular immunization elicited RV- and BCoV-specific serum antibodies, and the rLLR-GSG-P2A-BCoV CTD immunization modestly increased neutralizing antibody titers in colostrum. These findings establish the LLR strain as a genetically stable vector for the delivery of heterologous coronavirus antigens and support further evaluation of rotavirus-vectored vaccines for controlling viral coinfections that contribute to neonatal calf diarrhea. IMPORTANCE: Neonatal calf diarrhea is frequently caused by more than one enteric pathogen, yet most vaccines target individual agents. We developed recombinant rotaviruses that express neutralizing-antibody targets from the bovine coronavirus spike protein. The vaccine candidates rLLR-GSG-P2A-BCoV CTD maintained efficient replication and stable antigen expression, induced antibodies against both viruses in mice, and increased neutralizing activity in the serum and colostrum of immunized cows. This study provides proof of concept for using a licensed rotavirus vaccine backbone as a bivalent platform against two major viral causes of calf diarrhea and identifies a strategy that could be adapted to other polymicrobial enteric diseases.

Authors

Institutions

Publication Details

Journal
Journal of Virology
Published
2026-11-13
DOI
https://doi.org/10.1128/jvi.01541-26
Primary Topic
Viral gastroenteritis research and epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A rotavirus-vectored bivalent vaccine elicits protective immunity against bovine coronavirus and rotavirus

Dongbo Sun, Jun Wang, Songkang Qin, Debin Yu et al.
Journal of Virology
Viral gastroenteritis research and epidemiology
article

A rotavirus-vectored bivalent vaccine elicits protective immunity against bovine coronavirus and rotavirus

Dongbo Sun, Jun Wang, Songkang Qin, Debin Yu, Xin Yin, Yuxin Han, Wang Xiu-fang, Yang Fan, Qi Jia, Haoyu Xiang, Kuanhao Li, Hechun Deng, Zhenchao Dong, Jiangang Zhao, Jitao Chang, Bingxin Yao
article en

Abstract

Bovine rotavirus (BRV) and bovine coronavirus (BCoV) are major causes of neonatal calf diarrhea and frequently occur as co-infections. Here, we engineered the Lanzhou lamb rotavirus vaccine strain LLR to express either the N-terminal domain (NTD) or the C-terminal domain (CTD) of the BCoV spike S1 subunit from a modified genome segment 8. The resulting viruses, rLLR-GSG-P2A-BCoV NTD and rLLR-GSG-P2A-BCoV CTD, replicated efficiently in cell culture, stably retained the inserted sequences through serial passage, and expressed the corresponding BCoV antigens. In a mouse model, oral inoculation of neonatal mice induced systemic antibody responses against both RV and BCoV. Maternal immunization in mice protected suckling mice against RV challenge and conferred partial protection against BCoV-associated diarrhea. In pregnant cows, intramuscular immunization elicited RV- and BCoV-specific serum antibodies, and the rLLR-GSG-P2A-BCoV CTD immunization modestly increased neutralizing antibody titers in colostrum. These findings establish the LLR strain as a genetically stable vector for the delivery of heterologous coronavirus antigens and support further evaluation of rotavirus-vectored vaccines for controlling viral coinfections that contribute to neonatal calf diarrhea. IMPORTANCE: Neonatal calf diarrhea is frequently caused by more than one enteric pathogen, yet most vaccines target individual agents. We developed recombinant rotaviruses that express neutralizing-antibody targets from the bovine coronavirus spike protein. The vaccine candidates rLLR-GSG-P2A-BCoV CTD maintained efficient replication and stable antigen expression, induced antibodies against both viruses in mice, and increased neutralizing activity in the serum and colostrum of immunized cows. This study provides proof of concept for using a licensed rotavirus vaccine backbone as a bivalent platform against two major viral causes of calf diarrhea and identifies a strategy that could be adapted to other polymicrobial enteric diseases.

Journal of Virology
Heilongjiang Bayi Agricultural University (CN), Chinese Academy of Agricultural Sciences (CN), Harbin Veterinary Research Institute (CN)
National Key Research and Development Program of China
Zero hunger, Good health and well-being
Viral gastroenteritis research and epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon